Roivant Sciences Ltd.
ROIV | NASDAQ
$36.33
-$0.58 (-1.57%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 31, 2026 | FY 2024 Mar 31, 2025 | FY 2023 Mar 31, 2024 | FY 2022 Mar 31, 2023 | FY 2021 Mar 31, 2022 | FY 2020 Mar 31, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -64.42 | -42.04 | 1.88 | -5.20 | -3.92 | -8.29 |
PEG Ratio | -0.81 | 0.40 | 0 | -0.41 | -0.58 | 0.05 |
PS Ratio | 2.33K | 251.93 | 249.73 | 166.84 | 59.84 | 281.46 |
PB Ratio | 4.25 | 1.56 | 1.37 | 4.54 | 2 | 3.53 |
P/FCF Ratio | -25.34 | -8.67 | -10.66 | -6.14 | -4.76 | -12 |
P/OCF Ratio | -25.61 | -8.72 | -10.68 | -6.24 | -4.88 | -12.13 |
OCF/S Ratio | -9.08K | -2.89K | -2.34K | -2.67K | -1.23K | -2.32K |
Debt / Equity Ratio | 0.02 | 0.02 | 0.08 | 0.42 | 0.17 | 0.13 |
Quick Ratio | 18.37 | 33.47 | 25.10 | 6.59 | 11.64 | 9.99 |
Current Ratio | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 | 9.99 |
Asset Turnover | 0 | 0.01 | 0 | 0.01 | 0.02 | 0.01 |
Interest Coverage | n/a | n/a | -23.72 | -28.93 | -172.10 | -381.24 |
Return on Equity | -6.62% | -3.67% | 72.86% | -87.15% | -51.01% | -42.64% |
Return on Assets | -5.23% | -3.16% | 60.21% | -42.23% | -32.70% | -30.09% |
Return on Invested Capital | -23.55% | -21.02% | -11.77% | -37.29% | -50.23% | -43.13% |
Dividend Yield | n/a | n/a | 0.07% | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | 0.14% | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | -0.62% | n/a | n/a | n/a |
Gross Profit Margin | 84.44% | 96.86% | 95.11% | 90.38% | 83.78% | 91.36% |
Net Profit Margin | -3.63K% | -591.96% | 13.29K% | -3.2K% | -1.53K% | -3.4K% |
Pretax Profit Margin | -3.2K% | -2.35K% | 13.96K% | -2.81K% | -1.67K% | -3.78K% |
Operating Profit Margin | -15.56K% | -3.83K% | -2.52K% | -2.57K% | -2.19K% | -4.5K% |
FCF Margin | -9.18K% | -2.91K% | -2.34K% | -2.72K% | -1.26K% | -2.34K% |
EBITDA Margin | -3.16K% | -2.3K% | 14.14K% | -2.66K% | -1.65K% | -3.76K% |
Add to Watchlist
Select watchlists to add or remove ROIV